# TASK-028

## Title

Production Readiness Sign-off

---

## Sprint

Sprint 06

---

## Objective

Run the complete Version 1 Definition of Done against the current state of the application and record a final go/no-go readiness assessment.

---

## Rationale

`docs/21-quality-checklist.md` ("Version 1 Definition of Done") and `docs/17-production-deployment.md` ("Definition of Done") both define the same closing gate: the platform is stable, the interface feels premium, predictions are understandable, documentation is complete, performance is smooth, the repository is clean, and the product communicates confidence. This is the final task of Sprint 06 and the final task of the entire Sprint 02–06 roadmap — it exists to confirm every prior sprint's work actually satisfies the frozen product-quality bar, not to introduce new functionality.

---

## Implementation Requirements

- Walk through `docs/21-quality-checklist.md` in full (Product Quality, Visual Quality, Layout Quality, Motion Quality, Interaction Quality, Prediction Quality, Performance Quality, Accessibility, Responsive Design, Error Handling, Code Quality, Repository Quality, Documentation, Design Consistency) and record a pass/fail per section.
- Walk through `docs/17-production-deployment.md` in full (Functional Requirements, Code Quality, User Experience, Performance, Accessibility, Browser Compatibility, SEO, Monitoring, Final Verification) and record a pass/fail per section.
- For any section marked fail, either fix it if it is reproducible/user-visible (per CLAUDE.md's bug-fixing scope) or explicitly document it as a known limitation with rationale (e.g. "live data source not connected — documented Version 1 scope limitation, not a defect").
- Confirm the CI pipeline (TASK-025) is green on the final commit.

---

## Acceptance Criteria

- [ ] Every section of `docs/21-quality-checklist.md` and `docs/17-production-deployment.md` has an explicit pass/fail/known-limitation recorded.
- [ ] Every reproducible, user-visible failure found is fixed.
- [ ] Every remaining known limitation is clearly distinguished from a defect, with rationale tied to documented Version 1 scope (e.g. `docs/00-product-dna.md`'s explicit non-goals, or the synthetic-data limitation already disclosed in `PredictionResult.warnings`).
- [ ] CI (TASK-025) is green on the commit this task concludes with.
- [ ] The final readiness assessment is included in the task completion summary.

---

## Dependencies

TASK-025, TASK-026, TASK-027

---

## Status

TODO

---

## Notes

This task is a verification and sign-off task, not an implementation task — per CLAUDE.md, do not use it as an opportunity for unsolicited refactoring or scope expansion. Anything found here that requires new product decisions (rather than a fix within existing documented scope) should be recorded as a backlog item, not implemented ad hoc.
